US 11433029
Formulation of an antibody and use thereof
granted A61KA61K9/19A61P
Quick answer
US patent 11433029 (Formulation of an antibody and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K9/19, A61P, A61P19/02, A61P29/00